Mitochondria in endothelial cells angiogenesis and function: current understanding and future perspectives

Z Luo, J Yao, Z Wang, J Xu - Journal of Translational Medicine, 2023 - Springer
Endothelial cells (ECs) angiogenesis is the process of sprouting new vessels from the
existing ones, playing critical roles in physiological and pathological processes such as …

[HTML][HTML] Ferrochelatase: mapping the intersection of iron and porphyrin metabolism in the mitochondria

CD Obi, T Bhuiyan, HA Dailey… - Frontiers in Cell and …, 2022 - frontiersin.org
Porphyrin and iron are ubiquitous and essential for sustaining life in virtually all living
organisms. Unlike iron, which exists in many forms, porphyrin macrocycles are mostly …

Endothelial cells require functional FLVCR1a during developmental and adult angiogenesis

S Petrillo, F De Giorgio, F Bertino, F Garello, V Bitonto… - Angiogenesis, 2023 - Springer
Abstract The Feline Leukemia Virus Subgroup C Receptor 1a (FLVCR1a) is a
transmembrane heme exporter essential for embryonic vascular development. However, the …

STING up-regulates VEGF expression in oxidative stress-induced senescence of retinal pigment epithelium via NF-κB/HIF-1α pathway

Q Chen, L Tang, Y Zhang, C Wan, X Yu, Y Dong… - Life sciences, 2022 - Elsevier
Aim Aging-related dysfunction of retinal pigment epithelium (RPE) is the main pathogenic
factors for pathological angiogenesis due to dysregulated vascular endothelial growth factor …

A nanogel formulation of anti-VEGF peptide for ocular neovascularization treatment

S Durak, HE Sutova, R Ceylan, A Aciksari… - ACS Applied Bio …, 2024 - ACS Publications
Age-related macular degeneration (AMD) is an eye disorder that can lead to visual
impairment in elder patients, and current treatments include repeated injections of …

Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy

D Chobisa, A Muniyandi, K Sishtla, TW Corson, Y Yeo - Small, 2024 - Wiley Online Library
Neovascular age‐related macular degeneration (nAMD) is a leading cause of vision loss in
older adults. nAMD is treated with biologics targeting vascular endothelial growth factor; …

Mitochondrial heme synthesis enzymes as therapeutic targets in vascular diseases

T Shetty, TW Corson - Frontiers in Pharmacology, 2020 - frontiersin.org
Mitochondrial function in endothelial cells (EC) is interconnected by a mesh of signaling
molecules that cross pathways often (Kluge et al., 2013). One such versatile biomolecule is …

Heme synthesis inhibition blocks angiogenesis via mitochondrial dysfunction

T Shetty, K Sishtla, B Park, MJ Repass, TW Corson - Iscience, 2020 - cell.com
The relationship between heme metabolism and angiogenesis is poorly understood. The
final synthesis of heme occurs in mitochondria, where ferrochelatase (FECH) inserts Fe 2+ …

Small-molecule inhibitors of ferrochelatase are antiangiogenic agents

K Sishtla, N Lambert-Cheatham, B Lee, DH Han… - Cell chemical …, 2022 - cell.com
Activity of the heme synthesis enzyme ferrochelatase (FECH) is implicated in multiple
diseases. In particular, it is a mediator of neovascularization in the eye and thus an …

Pharmacological potential of small molecules for treating corneal neovascularization

Z Barry, B Park, TW Corson - Molecules, 2020 - mdpi.com
Under healthy conditions, the cornea is an avascular structure which allows for transparency
and optimal visual acuity. Its avascular nature is maintained by a balance of proangiogenic …